Stock News

Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses
Were Hedge Funds Right About Cutting Johnson & Johnson (JNJ)?
The Number of Covid-19 Cases Is Rising. What Comes Next.
Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO
Buy Opko Stock For Two Ways to Play the Ongoing Pandemic
Will Legal Problems Bankrupt Johnson & Johnson?
Better Buy: Eli Lilly vs. Johnson & Johnson
J&J scraps late-stage study testing Stelara for lupus
Bayer Isn’t Out of the Roundup Woods as 30,000 Claims Remain

As seen on...